{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:22:21Z","timestamp":1783394541953,"version":"3.54.6"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":285,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004248","name":"Psoriasis and Psoriatic Arthritis Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004248","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Inflammatory arthritis (IA) is associated with a high comorbidity burden, yet few studies have compared comorbidities across IA subtypes. We aimed to compare 39 comorbidities across RA, PsA and axial spondyloarthritis (axSpA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used UK Biobank data from over 500\u2009000 participants aged 40\u201369\u2009years. Baseline data for IA and comorbidities were identified via ICD-10 codes, primary care records and\/or self-report. Analysis of variance (ANOVA) and chi-squared tests were used for group comparisons, and logistic regression was used to estimate adjusted odds ratios (ORs) for comorbidities in IA versus controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 230\u2009055 participants (45.4% male; mean age 56.5\u2009years), 1969 had RA, 606 PsA and 797 axSpA. Hypertension (prevalence 9.0\u201311.1%) and dyspepsia (5.3\u20137.9%) were more prevalent in IA than in controls. Individuals with RA had significantly higher odds of atherosclerotic cardiovascular diseases, including coronary artery disease (OR 2.1, 95% confidence interval [CI] 1.66, 2.67), stroke\/transient ischaemic attack (TIA) (OR 1.78, 95% CI 1.09, 2.89) and peripheral vascular disease (OR 1.90, 95% CI 1.21, 2.99). Those with axSpA had higher odds of heart failure (OR 2.37, 95% CI 1.29, 4.34), atrial fibrillation (OR 1.59, 95% CI 1.03, 2.45) and epilepsy (OR 2.33, 95% CI 1.10, 4.94).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IA is linked to increased comorbidity prevalence, notably in cardiovascular, respiratory and gastrointestinal systems. The prevalence and odds of developing atherosclerotic cardiovascular disease were highest in those with RA. Individuals with axSpA have increased odds of developing epilepsy. These findings highlight the diverse comorbidity profiles across IA subtypes and support tailored management approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rap\/rkaf121","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:55:54Z","timestamp":1760183754000},"source":"Crossref","is-referenced-by-count":2,"title":["The comparative prevalence of comorbidities across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis"],"prefix":"10.1093","volume":"9","author":[{"given":"Jacob C","family":"Williams","sequence":"first","affiliation":[{"name":"St James\u2019s University Hospital, Leeds Teaching Hospitals NHS Trust , Leeds,","place":["UK"]},{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Southworth","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, University of Manchester , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Rogers","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, University of Manchester , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizheng Steven","family":"Zhao","sequence":"additional","affiliation":[{"name":"Centre for Musculoskeletal Research, The University of Manchester , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"2025102919265317300_rkaf121-B1","volume-title":"StatPearls [internet]","author":"Poudel","year":"2024"},{"key":"2025102919265317300_rkaf121-B2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","article-title":"Comorbidities in psoriatic arthritis: a systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2021","journal-title":"Rheumatol Int"},{"key":"2025102919265317300_rkaf121-B3","doi-asserted-by":"crossref","first-page":"iv47","DOI":"10.1093\/rheumatology\/keaa246","article-title":"Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis","volume":"59","author":"Zhao","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"2025102919265317300_rkaf121-B4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/rheumatology\/kes262","article-title":"A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome","volume":"52","author":"Norton","year":"2013","journal-title":"Rheumatology"},{"key":"2025102919265317300_rkaf121-B5","first-page":"366","article-title":"The impact of co-morbidity on health-related quality of life in rheumatoid arthritis and osteoarthritis patients","volume":"33","author":"Geryk","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2025102919265317300_rkaf121-B6","volume-title":"StatPearls [internet]","author":"Benjamin","year":"2024"},{"key":"2025102919265317300_rkaf121-B7","doi-asserted-by":"crossref","first-page":"e029589","DOI":"10.1161\/JAHA.123.029589","article-title":"Initiation patterns of disease-modifying antirheumatic drugs that have potential to exacerbate heart failure","volume":"12","author":"Lee","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2025102919265317300_rkaf121-B8","first-page":"e225914","article-title":"Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease","volume":"83","author":"Yoshimura","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025102919265317300_rkaf121-B9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/kep458","article-title":"Fibromyalgic rheumatoid arthritis and disease assessment","volume":"49","author":"Pollard","year":"2010","journal-title":"Rheumatology"},{"key":"2025102919265317300_rkaf121-B10","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1093\/rheumatology\/keac210","article-title":"All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study","volume":"61","author":"Kerola","year":"2022","journal-title":"Rheumatology"},{"key":"2025102919265317300_rkaf121-B11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"2025102919265317300_rkaf121-B12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.12968\/bjcn.2022.27.5.232","article-title":"The prevalence of comorbidity in rheumatoid arthritis: a systematic review and meta-analysis","volume":"27","author":"Hill","year":"2022","journal-title":"Br J Community Nurs"},{"key":"2025102919265317300_rkaf121-B13","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","article-title":"The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis","volume":"52","author":"Matcham","year":"2013","journal-title":"Rheumatology"},{"key":"2025102919265317300_rkaf121-B14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.chest.2024.02.014","article-title":"Does rheumatoid arthritis increase the risk of COPD?: a nationwide retrospective cohort study","volume":"165","author":"Chung","year":"2024","journal-title":"CHEST"},{"key":"2025102919265317300_rkaf121-B15","doi-asserted-by":"crossref","first-page":"1479973121994565","DOI":"10.1177\/1479973121994565","article-title":"A causal relationship between rheumatoid arthritis and bronchiectasis? A systematic review and meta-analysis","volume":"18","author":"Wiater","year":"2021","journal-title":"Chron Respir Dis"},{"key":"2025102919265317300_rkaf121-B16","doi-asserted-by":"crossref","first-page":"e223345","DOI":"10.1001\/jamanetworkopen.2022.3345","article-title":"Development of open-angle glaucoma in adults with seropositive rheumatoid arthritis in Korea","volume":"5","author":"Kim","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025102919265317300_rkaf121-B17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/1756-185X.12580","article-title":"Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis","volume":"18","author":"Nas","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"2025102919265317300_rkaf121-B18","doi-asserted-by":"crossref","first-page":"e531\u20137","DOI":"10.3399\/bjgp17X691877","article-title":"Improving recognition of anxiety and depression in rheumatoid arthritis: a qualitative study in a community clinic","volume":"67","author":"Machin","year":"2017","journal-title":"Br J Gen Pract"},{"key":"2025102919265317300_rkaf121-B19","doi-asserted-by":"crossref","first-page":"e0229819","DOI":"10.1371\/journal.pone.0229819","article-title":"Tumor necrosis factor (TNF) blocking agents are associated with lower risk for Alzheimer\u2019s disease in patients with rheumatoid arthritis and psoriasis","volume":"15","author":"Zhou","year":"2020","journal-title":"PLOS One"},{"key":"2025102919265317300_rkaf121-B20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.berh.2019.01.002","article-title":"Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis","volume":"32","author":"Liew","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025102919265317300_rkaf121-B21","doi-asserted-by":"crossref","first-page":"782150","DOI":"10.3389\/fmed.2021.782150","article-title":"The risk of cardiovascular diseases in axial spondyloarthritis. Current insights","volume":"8","author":"Toussirot","year":"2021","journal-title":"Front Med"},{"key":"2025102919265317300_rkaf121-B22","doi-asserted-by":"crossref","first-page":"e003485","DOI":"10.1136\/rmdopen-2023-003485","article-title":"Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated","volume":"9","author":"Raadsen","year":"2023","journal-title":"RMD Open"},{"key":"2025102919265317300_rkaf121-B23","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1007\/s00296-024-05740-z","article-title":"A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort","volume":"44","author":"Gu\u0142a","year":"2024","journal-title":"Rheumatol Int"},{"key":"2025102919265317300_rkaf121-B24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jbspin.2017.07.006","article-title":"Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: an ancillary study of the ASAS-COMOSPA project","volume":"85","author":"L\u00f3pez-Medina","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2025102919265317300_rkaf121-B25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/annrheumdis-2024-eular.4769","article-title":"Pos0520 inflammatory bowel disease in axial spondyloarthritis patients. Is there any specific clinical picture?","volume":"83","author":"Paredes","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025102919265317300_rkaf121-B26","doi-asserted-by":"crossref","first-page":"e003836","DOI":"10.1136\/rmdopen-2023-003836","article-title":"Frequency of irritable bowel syndrome in spondyloarthritis: a multicentric cross-sectional study and meta-analysis","volume":"10","author":"Bernard","year":"2024","journal-title":"RMD Open"},{"key":"2025102919265317300_rkaf121-B27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","article-title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study","volume":"75","author":"Molt\u00f3","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025102919265317300_rkaf121-B28","doi-asserted-by":"crossref","first-page":"106325","DOI":"10.1016\/j.phrs.2022.106325","article-title":"TNF inhibitors have a protective role in the risk of dementia in patients with ankylosing spondylitis: results from a nationwide study","volume":"182","author":"Watad","year":"2022","journal-title":"Pharmacol Res"},{"key":"2025102919265317300_rkaf121-B29","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/1756-185X.14147","article-title":"Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis","volume":"24","author":"Loganathan","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2025102919265317300_rkaf121-B30","doi-asserted-by":"crossref","first-page":"1759720X241271886","DOI":"10.1177\/1759720X241271886","article-title":"Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy","volume":"16","author":"Williams","year":"2024","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025102919265317300_rkaf121-B31","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2025102919265317300_rkaf121-B32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s43587-022-00277-x","article-title":"The limitations of large-scale volunteer databases to address inequalities and global challenges in health and aging","volume":"2","author":"Brayne","year":"2022","journal-title":"Nat Aging"},{"key":"2025102919265317300_rkaf121-B33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1759720X16643340","article-title":"Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps","volume":"8","author":"Zegkos","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025102919265317300_rkaf121-B34","first-page":"203","article-title":"Initiation of disease-modifying therapies in rheumatoid arthritis is associated with changes in blood pressure","volume":"24","author":"Baker","year":"2018","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"2025102919265317300_rkaf121-B35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10067-021-06003-z","article-title":"Effect of JAK inhibitors on high- and low-density lipoprotein in patients with rheumatoid arthritis: a systematic review and network meta-analysis","volume":"41","author":"Li","year":"2022","journal-title":"Clin Rheumatol"},{"key":"2025102919265317300_rkaf121-B36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"2025102919265317300_rkaf121-B37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.rdc.2017.09.005","article-title":"Gastrointestinal and hepatic disease in rheumatoid arthritis","volume":"44","author":"Craig","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"2025102919265317300_rkaf121-B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.34","article-title":"Obesity","volume":"3","author":"Gonz\u00e1lez-Muniesa","year":"2017","journal-title":"Nat Rev Dis Primer"},{"key":"2025102919265317300_rkaf121-B39","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/rheumatology\/keac403","article-title":"Association between psoriatic disease and lifestyle factors and comorbidities: cross-sectional analysis and Mendelian randomization","volume":"62","author":"Zhao","year":"2023","journal-title":"Rheumatol Oxf Engl"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkaf121\/64660181\/rkaf121.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/4\/rkaf121\/64660181\/rkaf121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/4\/rkaf121\/64660181\/rkaf121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T23:27:00Z","timestamp":1761780420000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkaf121\/8284937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9,13]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkaf121","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rkaf121"}}